Fig 3. Adjusted odds ratios of the effect of cumulative ICS dose exposure and measured in fluticasone equivalents from the first prescription at the index date to the last HbA_1c value in the outcome period.

*Adjusted for baseline HbA_1c and acute oral corticosteroid use between index date and outcome HbA_1c. ^†Adjusted for duration of diabetes (combined first diagnosis and first prescription), baseline HbA_1c and acute oral corticosteroid use between index date and outcome HbA_1c. HbA_1c = glycated haemoglobin; ICS = inhaled corticosteroids.